Alzheimer Forschungsinitiative e.V. Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2010
NCT01078168
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Alzheimer Forschungsinitiative e.V. (AFI)

Active Ingredients

Drugs in Phase 2 Trials (1)

acitretin (soriatane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1